Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1Phase 1 1

Status

Completed 33Terminated 5Active not recruiting 2

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 2Plasma cell 1

Conditions

Lymphoma, Follicular 2Hemangioma 2Multiple Myeloma 1

Interventions

Cyclophosphamide 222pembrolizumab 201Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 155Docetaxel 140Bevacizumab 138Rituximab 137Radiotherapy 137Nivolumab 126Dexamethasone 126Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 63Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × Has results × Prednisolone × Clear all
NCT01370694 2019-03-15

Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)

Merck Sharp & Dohme LLC

Phase 1 Terminated
7 enrolled 7 charts
Lymphoid

Lymphoma, Follicular

NCT01074437 2018-10-04

Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)

Seattle Children's Hospital

Phase 2 Terminated
9 enrolled 5 charts

Hemangioma

NCT00562965 2018-01-09

Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)

Pfizer

Phase 3 Terminated
29 enrolled 14 charts
Lymphoid

Lymphoma, Follicular

NCT00967226 2016-02-24

Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas

Children's National Research Institute

Phase 2 Terminated
19 enrolled 25 charts

Hemangioma

NCT01179490 2013-03-18

Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma

SymBio Pharmaceuticals

Phase 2 Terminated
5 enrolled 30 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡